Therefore, we predict that green tea peptide, as a food-derived ACE-inhibiting peptide with high safety and low toxicity, may be expected to replace drugs with similar mechanisms and be used in combination with other antihypertensive drugs for the clinical treatment of hypertension and hypertensive nephropathy. This evidence concerns the gene ACE and hypertensive nephropathy.